Cardiac Optogenetics: A move in the light direction
For a human heart to pump blood through our circulatory system, billions of muscle cells, called cardiomyocytes, must contract in a well-orchestrated manner. Ordered contraction is achieved via sequential electrical excitation of cells. Cardiomyocytes are excited when a sufficiently strong electric stimulus causes them to depolarize; they then remain in their activated state for some time; and, lastly, they return to their resting state, ready to be activated again. For normal heartbeats, electrical excitation originates from specialized pacemaker cells in the sinus node of the heart, which depolarize automatically. This rhythmically generated electrical signal then propagates along cardiomyocytes throughout the heart. A short time after depolarization, cardiomyocytes contract. Thus, rhythmical electrical activity leads to a regular heartbeat.
Cardiac arrhythmias can be caused by various factors – such as diseased cells and scar tissue – and they are associated with serious clinical conditions, including myocardial infarction, heart failure, and sudden cardiac death. One specific mechanism responsible for cardiac arrhythmia is so-called re-entrant electrical activity: this happens when the electrical impulse that excites cardiomyocytes does not terminate after all cells have been activated. Instead, due to pathological changes in cell or tissue properties, the excitation wave finds a way to circle back and re-activate cells out-of-turn. Under certain conditions, a self-sustaining ‘rotor’ can form, where electrical activity keeps circling in the heart for extended periods of time. While rotating, it emits spiral waves of electrical excitation that override the normal heart rhythm (Pandit and Jalife, 2013; Figure 1A).
One elegant way to study mechanisms of cardiac arrhythmias is optogenetics. In cardiac optogenetics, light-sensitive proteins are expressed in heart cells and are used to monitor or steer their electrical properties and function (Schneider-Warme, 2018; Zgierski-Johnston and Schneider-Warme, 2021). For example, blue light can be used to activate an ion-channel protein called channelrhodopsin-2, which results in the depolarization of cells. By activating this protein in cardiomyocytes, researchers have already successfully generated optical pacemakers (Arrenberg et al., 2010; Bruegmann et al., 2010) and conducted optical defibrillation in animal models (Bruegmann et al., 2018; Bruegmann et al., 2016; Crocini et al., 2016; Nyns et al., 2017). Now, in eLife, Stefan Luther and colleagues – including Sayedeh Hussaini as first author – report that low-intensity light may be used to steer rotors (Hussaini et al., 2021). Using a combination of cardiac optogenetics and computational modelling, they describe guiding rotors towards locations where re-entrant electrical activity is no longer possible, thereby terminating cardiac arrhythmias.
Computational modelling has long been used by cardiac researchers to explore how cellular (and sub-cellular) mechanisms act together in healthy or diseased heart tissue (Loewe et al., 2018). Hussaini et al. started with an established mathematical model of cardiomyocyte electrical activity (Petkova-Kirova et al., 2012) and added differential equations that describe light-activated currents mediated by channelrhodopsin-2 (Williams et al., 2013). A reaction-diffusion equation (the so-called monodomain model) was then used to couple multiple model cells in a two-dimensional tissue model.
Utilizing this model, the researchers – who are based at the Max Planck Institute for Dynamics and Self-Organization in Göttingen, the University of Göttingen and other institutions in Germany, France, Italy and Canada – first investigated the effect of illumination with intensities so low that the cardiomyocytes were slightly depolarized from their resting state, but were not excited. They found that increasing the intensity of such ‘sub-threshold’ illumination has two effects: it decreases the velocity at which electrical excitation is relayed from cell to cell, and it decreases the dominant frequency of spiral waves. Both results are in keeping with classically expected single-cell behaviour, but Hussaini et al. confirmed them in real tissue for the first time by performing ex vivo experiments with intact mouse hearts.
Next, Hussaini et al. simulated what could happen when using sub-threshold illumination with linearly graded light intensity. They found that the rotor – which previously had been stable – tended to move towards the part of the tissue where the light intensity was higher (Figure 1B). Moreover, the steeper the gradient, the faster the rotor moved. In another simulation, one region of the tissue was exposed to light of constant, low intensity, while the remaining tissue was not illuminated: here the rotor moved to the illuminated region (Figure 1C). Finally, they predicted that successive partial illuminations of the 2D tissue could be used to steer the rotor to parts of the tissue where the rotor could not continue to self-sustain.
Hussaini and colleagues propose a novel approach for the termination of cardiac arrhythmias using sub-threshold illumination. In fact, the underlying mechanism may have played a role in previous breakthroughs in cardiac optogenetics, such as the demonstration of optical defibrillation in animal models mentioned above. Further work is needed to verify effects of interventions proposed based on computational modelling, as hearts are characterized not only by a complex geometry, but also by tissue heterogeneities that rotors might become anchored to. Looking to the future, the obvious question is whether optogenetic modulation of cardiac electrophysiology, as described here, may ultimately be used to terminate arrhythmias in humans. Answering this question will require further research – it will be necessary, for example, to overcome the challenges associated with the expression of light-gated channels in cardiomyocytes, and with targeted light delivery. The work reported in this paper is undoubtedly an important step in the light direction.
References
-
Optogenetic control of heart muscle in vitro and in vivoNature Methods 7:897–900.https://doi.org/10.1038/nmeth.1512
-
Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulationsJournal of Clinical Investigation 126:3894–3904.https://doi.org/10.1172/JCI88950
-
Optogenetic termination of atrial fibrillation in miceCardiovascular Research 114:713–723.https://doi.org/10.1093/cvr/cvx250
-
Cardiac ischemia—insights from computational modelsHerzschrittmachertherapie + Elektrophysiologie 29:48–56.https://doi.org/10.1007/s00399-017-0539-6
-
Rotors and the dynamics of cardiac fibrillationCirculation Research 112:849–862.https://doi.org/10.1161/CIRCRESAHA.111.300158
-
Mathematical modeling mechanisms of arrhythmias in transgenic mouse heart overexpressing TNF-αAmerican Journal of Physiology-Heart and Circulatory Physiology 302:H934–H952.https://doi.org/10.1152/ajpheart.00493.2011
-
The power of optogenetics: potential in cardiac experimental and clinical electrophysiologyHerzschrittmachertherapie + Elektrophysiologie 29:24–29.https://doi.org/10.1007/s00399-017-0545-8
-
Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 modelPLOS Computational Biology 9:e1003220.https://doi.org/10.1371/journal.pcbi.1003220
-
Observing and manipulating cell-specific cardiac function with lightAdvances in Experimental Medicine and Biology 1293:377–388.https://doi.org/10.1007/978-981-15-8763-4_24
Article and author information
Author details
Publication history
Copyright
© 2021, Wülfers and Schneider-Warme
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 936
- views
-
- 94
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
- Neuroscience
Entorhinal grid cells implement a spatial code with hexagonal periodicity, signaling the position of the animal within an environment. Grid maps of cells belonging to the same module share spacing and orientation, only differing in relative two-dimensional spatial phase, which could result from being part of a two-dimensional attractor guided by path integration. However, this architecture has the drawbacks of being complex to construct and rigid, path integration allowing for no deviations from the hexagonal pattern such as the ones observed under a variety of experimental manipulations. Here, we show that a simpler one-dimensional attractor is enough to align grid cells equally well. Using topological data analysis, we show that the resulting population activity is a sample of a torus, while the ensemble of maps preserves features of the network architecture. The flexibility of this low dimensional attractor allows it to negotiate the geometry of the representation manifold with the feedforward inputs, rather than imposing it. More generally, our results represent a proof of principle against the intuition that the architecture and the representation manifold of an attractor are topological objects of the same dimensionality, with implications to the study of attractor networks across the brain.
-
- Computational and Systems Biology
- Physics of Living Systems
Planar cell polarity (PCP) – tissue-scale alignment of the direction of asymmetric localization of proteins at the cell-cell interface – is essential for embryonic development and physiological functions. Abnormalities in PCP can result in developmental imperfections, including neural tube closure defects and misaligned hair follicles. Decoding the mechanisms responsible for PCP establishment and maintenance remains a fundamental open question. While the roles of various molecules – broadly classified into ‘global’ and ‘local’ modules – have been well-studied, their necessity and sufficiency in explaining PCP and connecting their perturbations to experimentally observed patterns have not been examined. Here, we develop a minimal model that captures the proposed features of PCP establishment – a global tissue-level gradient and local asymmetric distribution of protein complexes. The proposed model suggests that while polarity can emerge without a gradient, the gradient not only acts as a global cue but also increases the robustness of PCP against stochastic perturbations. We also recapitulated and quantified the experimentally observed features of swirling patterns and domineering non-autonomy, using only three free model parameters - rate of protein binding to membrane, the concentration of PCP proteins, and the gradient steepness. We explain how self-stabilizing asymmetric protein localizations in the presence of tissue-level gradient can lead to robust PCP patterns and reveal minimal design principles for a polarized system.